Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Kite and HiFiBiO Therapeutics Partner to Discover Novel Targets and Antibodies Against Acute Myeloid Leukemia
Friday, September 04, 2020Kite a Gilead Company and HiFiBiO Therapeutics announced the companies have entered into a twoyear research collaboration and license agreement in acute myeloid leukemia AML Through this collaboration HiFiBiO will use its proprietary technology platf...
PPD and Lupus Therapeutics Collaborate to Support Lupus Clinical Research
Friday, September 04, 2020PPD Inc a leading global contract research organization and Lupus Therapeutics LT an affiliate of the Lupus Research Alliance known for its lupus clinical trials expertise have entered into a collaboration to expand and enhance lupus clinical researc...
Igyxos and Selexis Enter Service Agreement to Advance Igyxos’ First-In-Class Monoclonal Antibody for the Treatment of Human Infertility
Thursday, September 03, 2020Selexis SA and Igyxos announced that they have entered into a service agreement to develop Igyxos firstinclass monoclonal antibody mAb drug candidate for the treatment of human infertility Under the agreement Igyxos will utilize Selexis proprietary S...
BiomX Enters Collaboration with Boehringer Ingelheim with the Goal of Discovering Microbiome-Based Biomarkers for Inflammatory Bowel Disease
Thursday, September 03, 2020BiomX Inc a clinical stage company developing natural and engineered phage therapies that target specific pathogenic bacteria announced that it has entered into a collaboration with Boehringer Ingelheim to utilize the BiomX XMarker microbiomebased bi...
ReVision Therapeutics, Inc. Announces License with Cornell to Develop Treatment for Stargardt Disease
Wednesday, September 02, 2020ReVision Therapeutics Inc a privatelyheld early stage biopharmaceutical company focused on the development and commercialization of innovative therapies for ocular and rare diseases announced that it has signed an exclusive license agreement with Cor...
Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program
Wednesday, September 02, 2020Gilead Sciences Incannounced an agreement with Jounce Therapeutics Inc a clinicalstage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers to exclusively license its JTX program
Vor Biopharma and Metagenomi to Collaborate on Engineered Hematopoietic Stem-Cell Therapies
Tuesday, September 01, 2020Vor Biopharma an oncology company pioneering engineered hematopoietic stem cells eHSCs for the treatment of cancer and Metagenomi a gene editing company discovering breakthrough systems for curing genetic disease today announced that Vor will evaluat...
Applied BioMath, LLC Announces Collaboration with Flame Biosciences for Systems Pharmacology Modeling in Lung Cancer
Tuesday, September 01, 2020Applied BioMath wwwappliedbiomathcom the industryleader in applying systems pharmacology and mechanistic modeling simulation and analysis to derisk drug research and development announced a collaboration with Flame Biosciences Flame Biosciences selec...
Seneca Therapeutics, Inc. Licenses Tumor Endothelial Marker 8 (TEM8) to Enable Better Patient Selection for SVV-001 Therapy
Monday, August 31, 2020Seneca Therapeutics Inc a clinicalstage biopharmaceutical company dedicated to the development of oncolytic immunetherapeutics based on Seneca Valley Virus SVV announced the company has licensed TEM intellectual property from Memorial Sloan Ketterin...
IBio and Planet Biotechnology Enter into Exclusive Worldwide License Agreement for the Development of a COVID-19 Therapeutic
Saturday, August 29, 2020IBio Inca biotechnology innovator and biologics contract manufacturing organization announced that it has entered into an exclusive worldwide license agreement with Planet Biotechnology Inc Planet for the development of Planets COVID therapeutic cand...
